Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TECLISTAMAB vs TEDUGLUTIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TECLISTAMAB vs TEDUGLUTIDE: Safety Overview

Metric TECLISTAMAB TEDUGLUTIDE
Total FAERS Reports 1,221 8,774
Deaths Reported 269 788
Death Rate 22.0% 9.0%
Hospitalizations 540 5,977
Average Patient Age 66.5 yrs 50.6 yrs
% Female Patients 45.7% 62.0%
FDA Approval Date N/A Dec 21, 2012
Manufacturer Janssen Biotech, Inc. Takeda Pharmaceuticals America, Inc.
Route SUBCUTANEOUS SUBCUTANEOUS
Marketing Status N/A Prescription